Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Clinical trial NCT04996017 · RECRUITING
Trial details
- NCT number
- NCT04996017
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2027-07-30
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.